Literature DB >> 22008433

Roles of prostaglandin E2 in cardiovascular diseases.

Jun-ichi Suzuki1, Masahito Ogawa, Ryo Watanabe, Kiyoshi Takayama, Yasunobu Hirata, Ryozo Nagai, Mitsuaki Isobe.   

Abstract

Prostaglandin E2 (PGE(2)) is produced in inflammatory responses and regulates a variety of immunological reactions through 4 different receptor subtypes; EP1, 2, 3 and 4. However, the precise role of each receptor in cardiovascular disease has not yet been elucidated. Enhanced expression of some EPs has been observed in clinical and experimental cardiovascular diseases. EP agonists have been developed to clarify the role of each receptor. Recently, we developed a novel selective agonist to examine the effects of EP4 on cardiac transplantation, myocardial ischemia, and myocarditis. Of note, a selective EP4 agonist attenuated inflammatory cytokines and chemokines via attenuation of macrophage activation in inflammatory heart diseases. In this review article, we discuss the effects of PGE(2) receptor agonists on the development of cardiovascular diseases.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22008433     DOI: 10.1536/ihj.52.266

Source DB:  PubMed          Journal:  Int Heart J        ISSN: 1349-2365            Impact factor:   1.862


  11 in total

1.  Myeloid cell microsomal prostaglandin E synthase-1 fosters atherogenesis in mice.

Authors:  Lihong Chen; Guangrui Yang; James Monslow; Leslie Todd; David P Cormode; Jun Tang; Gregory R Grant; Jonathan H DeLong; Soon Yew Tang; John A Lawson; Ellen Pure; Garret A Fitzgerald
Journal:  Proc Natl Acad Sci U S A       Date:  2014-04-21       Impact factor: 11.205

2.  α1 -Adrenoceptor activation of PKC-ε causes heterologous desensitization of thromboxane receptors in the aorta of spontaneously hypertensive rats.

Authors:  Yingzi Zhao; Paul M Vanhoutte; Susan W S Leung
Journal:  Br J Pharmacol       Date:  2015-05-15       Impact factor: 8.739

Review 3.  An eicosanoid-centric view of atherothrombotic risk factors.

Authors:  Scott Gleim; Jeremiah Stitham; Wai Ho Tang; Kathleen A Martin; John Hwa
Journal:  Cell Mol Life Sci       Date:  2012-04-11       Impact factor: 9.261

4.  Prostaglandins E2 signal mediated by receptor subtype EP2 promotes IgE production in vivo and contributes to asthma development.

Authors:  Yuhan Gao; Chunyan Zhao; Wei Wang; Rong Jin; Qian Li; Qing Ge; Youfei Guan; Yu Zhang
Journal:  Sci Rep       Date:  2016-02-08       Impact factor: 4.379

5.  Consumption of Red Meat, but Not Cooking Oils High in Polyunsaturated Fat, Is Associated with Higher Arachidonic Acid Status in Singapore Chinese Adults.

Authors:  Jowy Yi Hoong Seah; Gibson Ming Wei Gay; Jin Su; E-Shyong Tai; Jian-Min Yuan; Woon-Puay Koh; Choon Nam Ong; Rob M van Dam
Journal:  Nutrients       Date:  2017-01-31       Impact factor: 5.717

6.  Intronic Variants in OCT1 are Associated with All-Cause and Cardiovascular Mortality in Metformin Users with Type 2 Diabetes.

Authors:  Natascha Schweighofer; Bernd Genser; Winfried Maerz; Marcus E Kleber; Olivia Trummer; Thomas R Pieber; Barbara Obermayer-Pietsch
Journal:  Diabetes Metab Syndr Obes       Date:  2020-06-18       Impact factor: 3.168

7.  Metabolomic and lipidomic profile in men with obstructive sleep apnoea: implications for diagnosis and biomarkers of cardiovascular risk.

Authors:  Adriana Lebkuchen; Valdemir M Carvalho; Gabriela Venturini; Jéssica S Salgueiro; Lunara S Freitas; Alessandra Dellavance; Franco C Martins; Geraldo Lorenzi-Filho; Karina H M Cardozo; Luciano F Drager
Journal:  Sci Rep       Date:  2018-07-26       Impact factor: 4.379

8.  Vasorelaxant Effects of the Vitex Agnus-Castus Extract.

Authors:  Shpëtim Thaçi; Berat Krasniqi; Miribane Dërmaku-Sopjani; Arleta Rifati-Nixha; Sokol Abazi; Mentor Sopjani
Journal:  Evid Based Complement Alternat Med       Date:  2022-03-22       Impact factor: 2.629

Review 9.  E-type prostanoid receptor 4 (EP4) in disease and therapy.

Authors:  Viktoria Konya; Gunther Marsche; Rufina Schuligoi; Akos Heinemann
Journal:  Pharmacol Ther       Date:  2013-03-21       Impact factor: 12.310

10.  Anti-atherogenic properties of vitamin E, aspirin, and their combination.

Authors:  Sheau C Chai; Elizabeth M Foley; Bahram H Arjmandi
Journal:  PLoS One       Date:  2018-10-25       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.